In pre-clinical trials, transient inhibition of ATM led to radiosensitization or chemosensitization in vivo and in vitro25–27, thus it is possible that ATM inhibitors strengthen the effects of anti-cancer drugs or irradiation. The gene discussed is ATM; the disease is cancer.